赛特克生物科技

最新新闻

• 评级变动
  TD Cowen Downgrades Cytek Biosciences(CTKB.US) to Hold Rating, Cuts Target Price to $4
  \u5e02\u573a\u8d44\u8baf · 2025/5/10
• 评级变动
  Goldman Sachs Downgrades Cytek Biosciences(CTKB.US) to Sell Rating, Cuts Target Price to $5.25
  \u5e02\u573a\u8d44\u8baf · 2025/1/31
• 评级变动
  Piper Sandler Maintains Cytek Biosciences(CTKB.US) With Buy Rating, Cuts Target Price to $8
  \u5e02\u573a\u8d44\u8baf · 2025/3/4
• 评级变动
  Piper Sandler Maintains Cytek Biosciences(CTKB.US) With Buy Rating, Maintains Target Price $8
  \u5e02\u573a\u8d44\u8baf · 2025/8/11
• Stephens Maintains Cytek Biosciences(CTKB.US) With Buy Rating, Raises Target Price to $4.75
  \u5e02\u573a\u8d44\u8baf · 2026/5/13
• 评级变动
  Morgan Stanley Maintains Cytek Biosciences(CTKB.US) With Hold Rating, Maintains Target Price $9
  \u5e02\u573a\u8d44\u8baf · 2025/3/14
• 评级变动
  TD Cowen Maintains Cytek Biosciences(CTKB.US) With Hold Rating, Raises Target Price to $5
  \u5e02\u573a\u8d44\u8baf · 2026/2/27
• 评级变动
  Goldman Sachs Initiates Cytek Biosciences(CTKB.US) With Sell Rating, Announces Target Price $4.5
  \u5e02\u573a\u8d44\u8baf · 2025/1/31
• Piper Sandler Maintains Cytek Biosciences(CTKB.US) With Buy Rating, Maintains Target Price $7.5
  \u5e02\u573a\u8d44\u8baf · 2026/8/6
• Morgan Stanley Maintains Cytek Biosciences(CTKB.US) With Hold Rating, Cuts Target Price to $5
  \u5e02\u573a\u8d44\u8baf · 2026/8/6
• 评级变动
  Morgan Stanley Initiates Cytek Biosciences(CTKB.US) With Hold Rating, Announces Target Price $6
  \u5e02\u573a\u8d44\u8baf · 2025/12/2
• 评级变动
  TD Cowen Maintains Cytek Biosciences(CTKB.US) With Hold Rating, Maintains Target Price $4
  \u5e02\u573a\u8d44\u8baf · 2025/11/6
• 评级变动
  Stephens Maintains Cytek Biosciences(CTKB.US) With Buy Rating, Cuts Target Price to $4
  \u5e02\u573a\u8d44\u8baf · 2025/5/17
• 评级变动
  Morgan Stanley Maintains Cytek Biosciences(CTKB.US) With Hold Rating, Cuts Target Price to $7
  \u5e02\u573a\u8d44\u8baf · 2025/5/29
• 评级变动
  Piper Sandler Maintains Cytek Biosciences(CTKB.US) With Buy Rating, Cuts Target Price to $7.5
  \u5e02\u573a\u8d44\u8baf · 2025/11/11
• 评级变动
  Piper Sandler Maintains Cytek Biosciences(CTKB.US) With Buy Rating, Cuts Target Price to $8.25
  \u5e02\u573a\u8d44\u8baf · 2024/11/25
• Morgan Stanley Maintains Cytek Biosciences(CTKB.US) With Hold Rating, Cuts Target Price to $4.12
  \u5e02\u573a\u8d44\u8baf · 2026/5/12
• 评级变动
  Piper Sandler Maintains Cytek Biosciences(CTKB.US) With Buy Rating, Maintains Target Price $8.25
  \u5e02\u573a\u8d44\u8baf · 2025/2/28
• TD Cowen Maintains Cytek Biosciences(CTKB.US) With Hold Rating, Maintains Target Price $5
  \u5e02\u573a\u8d44\u8baf · 2026/8/6
• 评级变动
  TD Cowen Maintains Cytek Biosciences(CTKB.US) With Buy Rating, Cuts Target Price to $7
  \u5e02\u573a\u8d44\u8baf · 2025/2/28

新闻标题为自动聚合内容，未经我们团队独立核实或编辑。